Carcinoid Tumor Diagnosis and Treatment - A Detailed Guide

Carcinoid tumors are slow-growing and rare neuroendocrine tumors. The clinicians experience diagnostic challenges, as most patients do not have any symptoms in the early stages. If the symptoms do exist, they overlap with other, less serious conditions. A multidisciplinary approach is required for optimal carcinoid tumor treatment, with surgery being the only curative option. Carcinoid syndrome diagnostic tests may also be performed in patients with carcinoid tumors, especially those with advanced stages.

Carcinoid Tumor Diagnostic Tests

A carcinoid tumor diagnosis begins with a physical examination and a medical history assessment. The doctor will initially try to understand the causes of the symptoms experienced by the patient. If the doctor suspects carcinoid tumors, additional tests will be recommended. The following are the different tests recommended for carcinoid tumor diagnosis:

Treatment for carcinoid tumor

Effective carcinoid tumor treatment involves a multidisciplinary approach that includes surgical resection, debulking, medical therapy, and hepatic chemoembolization. The different options available for carcinoid tumor treatment include:

Why Choose HCG for Carcinoid Tumor Diagnosis and Treatment?

Carcinoid tumor diagnosis and treatment are challenging, especially in patients who are diagnosed in advanced stages. It requires advanced facilities for diagnosis and treatment, a team to perform complex surgeries, state-of-the-art operating theaters, and experienced paramedical staff to take care before and after the treatment. HCG is one of the highly recommended cancer hospitals in India for carcinoid tumor diagnosis and treatment and is equipped with all facilities that increase the chances of a favorable prognosis and improve the overall quality of life of the patients.


Methods for carcinoid tumor diagnosis include blood tests, urine tests, colonoscopy, appendicitis, upper endoscopy, biochemical tests, imaging tests, biopsy, and radionuclide scanning. The options for carcinoid tumor treatment include surgery, medications to control excess hormones, chemotherapy, radiation therapy, targeted drug therapy, somatostatin analogs, and immunotherapy.

Frequently Asked Questions

Several new carcinoid tumor treatments have been approved, and several are under clinical research. Targeted therapy, such as peptide receptor radionuclide therapy, is one of the most advanced treatments for carcinoid tumors.

Several carcinoid tumor diagnosis methods are available to detect the spread of carcinoid tumors. These include imaging methods such as CT scans and MRI scans.

It is a carcinoid tumor test. 5-hydroxyindoleacetic acid (5-HIAA) is a serotonin metabolite. Patients with carcinoid tumors have increased levels of serotonin. The levels of 5-HIAA are also increased in the urine of such patients. In the 5-HIAA test, the levels of 5-HIAA are measured in the urine.

The biomarkers for carcinoid tumor investigation include 5-hydroxytryptamine, dopamine, histamine, atrial natriuretic peptide, neurotensin, α1-antitrypsin, somatostatin, pancreatic polypeptide, substance P, kallikrein, chromogranin, and prostaglandins.

The 24-hour urine collection is done to detect the presence of 5-HIAA in patients suspected of having carcinoid tumors.